‪Sooraj Mathukkada‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	40	40
h-index	3	3
i10-index	1	1

0

22

11

20212022202320242 5 21 12

Public access

2 articles

0 articles

available

not available

Based on funding mandates

Co-authors

SANKAR JAGADEESHANPost Doctoral Fellow, Ben Gurion University of the NegevVerified email at post.bgu.ac.il
Moshe ElkabetsProf. at the Ben-Gurion University of the NegevVerified email at bgu.ac.il
Manu PrasadMemorial sloan Kettering Cancer CentreVerified email at mskcc.org
katheeja muhseenaPhD scholarVerified email at yenepoya.edu.in

Sooraj Mathukkada

Sooraj Mathukkada

Ben-Gurion University of the Negev

Verified email at post.bgu.ac.il

Cancer Immunology Immunotherapy Tumor microenvironment.


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer M Prasad, J Zorea, S Jagadeeshan, AB Shnerb, S Mathukkada, ... Journal for ImmunoTherapy of Cancer 10 (3), 2022	25	2022
Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer S Jagadeeshan, M Prasad, M Badarni, T Ben-Lulu, VB Liju, ... Cancer research 83 (7), 1031-1047, 2023	8	2023
The repair gene BACH1-a potential oncogene S Mathukkada, SP Das, S Laha Oncology Reviews 15 (1), 2021	7	2021
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma S Jagadeeshan, K Suryamohan, N Shin, S Mathukkada, A Boyko, ... Oral Oncology 149, 106688, 2024		2024

The system can't perform the operation now. Try again later.

Articles 1–4